(2E)-1-(4-bromophenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

(2E)-1-(4-fluorophenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3-methylbicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 250mg

1-(5-Bromoquinoxalin-6-yl)thiourea, 95.0%, 5g

2,2,2-Trifluoroacetamide, 99.0%, 500g

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-Bromo-5-nitro-1H-imidazole, 97.0%, 1g

{2-[4-(2-pyrimidinyl)-1-piperazinyl]ethyl}amine trihydrochloride, 95.0%, 250mg

2,4,6-Trichloroiodobenzene, 97%, 100g

Diethyl 2,6-dimethylpyridine-3,5-dicarboxylate, 95.0%, 25g

3-Amino-4-hydroxy-N-methylbenzenesulfonamide, 95.0%, 100g

Ethyl 3,5-difluorobenzoylformate, 96.0%, 5g

4-Chloro-3-iodo-2-methoxypyridine, 97%, 250mg